Patheon, a global provider of drug development and delivery services to the pharma and biopharma industries, has completed its acquisition of an API manufacturing facility in Florence, SC, from Roche Holdings, Inc.   The 300,000 sq.-ft. facility has manufacturing capacity for API ranging from development to manufacturing services, expanding the company’s capacity for manufacturing highly potent compounds and adding capabilities to support solid-state chemistry, micronization, and eventually, c...